BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 37488669)

  • 21. Prevalence of Influenza Vaccination in Chronic Obstructive Pulmonary Disease Patients and Impact on the Risk of Severe Exacerbations.
    Garrastazu R; García-Rivero JL; Ruiz M; Helguera JM; Arenal S; Bonnardeux C; León C; Llorca J; Santibañez M
    Arch Bronconeumol; 2016 Feb; 52(2):88-95. PubMed ID: 26526292
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influenza vaccination rate and its association with chronic diseases in China: Results of a national cross-sectional study.
    Fan J; Cong S; Wang N; Bao H; Wang B; Feng Y; Lv X; Zhang Y; Zha Z; Yu L; Yang T; Wang L; Fang L
    Vaccine; 2020 Mar; 38(11):2503-2511. PubMed ID: 32046892
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influenza vaccination reduces hospitalization for acute coronary syndrome in elderly patients with chronic obstructive pulmonary disease: a population-based cohort study.
    Sung LC; Chen CI; Fang YA; Lai CH; Hsu YP; Cheng TH; Miser JS; Liu JC
    Vaccine; 2014 Jun; 32(30):3843-9. PubMed ID: 24837769
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influenza and Pneumococcal Vaccination Uptake in Patients with Rheumatoid Arthritis Treated with Immunosuppressive Therapy in the UK: A Retrospective Cohort Study Using Data from the Clinical Practice Research Datalink.
    Costello R; Winthrop KL; Pye SR; Brown B; Dixon WG
    PLoS One; 2016; 11(4):e0153848. PubMed ID: 27096429
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influenza Vaccine Effectiveness Pre-pandemic Among Adults Hospitalized With Congestive Heart Failure or Chronic Obstructive Pulmonary Disease and Older Adults.
    Tippett A; Ess G; Hussaini L; Reese O; Salazar L; Kelly M; Taylor M; Ciric C; Keane A; Cheng A; Gibson T; Li W; Hsiao HM; Bristow L; Hellmeister K; Al-Husein Z; Hubler R; Begier E; Liu Q; Gessner B; Swerdlow DL; Kamidani S; Kao C; Yildirim I; Rouphael N; Rostad CA; Anderson EJ
    Clin Infect Dis; 2024 Apr; 78(4):1065-1072. PubMed ID: 37946601
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cross-sectional study on the prevalence of influenza and pneumococcal vaccination and its association with health conditions and risk factors among hospitalized multimorbid older patients.
    Papazoglou DD; Baretella O; Feller M; Del Giovane C; Moutzouri E; Aujesky D; Schwenkglenks M; O'Mahony D; Knol W; Dalleur O; Rodondi N; Baumgartner C
    PLoS One; 2021; 16(11):e0260112. PubMed ID: 34784405
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence of influenza and pneumococcal vaccination in chronic obstructive pulmonary disease patients in association with the occurrence of acute exacerbations.
    Fekete M; Pako J; Nemeth AN; Tarantini S; Varga JT
    J Thorac Dis; 2020 Aug; 12(8):4233-4242. PubMed ID: 32944335
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Indicators of influenza and pneumococcal vaccination in French nursing home residents in 2011.
    de Souto Barreto P; Lapeyre-Mestre M; Vellas B; Rolland Y
    Vaccine; 2014 Feb; 32(7):846-51. PubMed ID: 24370710
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of pneumococcal and influenza vaccination coverage in rheumatology patients receiving biological therapy in a regional referral hospital.
    Fernández-Prada M; Brandy-García AM; Rodríguez-Fonseca OD; Huerta-González I; Fernández-Noval F; Martínez-Ortega C
    Reumatol Clin (Engl Ed); 2020; 16(2 Pt 1):97-102. PubMed ID: 29752214
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Compliance with influenza and pneumococcal vaccination among patients with chronic obstructive pulmonary disease consulting their medical practitioners in Catalonia, Spain.
    Jiménez-García R; Ariñez-Fernandez MC; Hernández-Barrera V; Garcia-Carballo MM; de Miguel AG; Carrasco-Garrido P
    J Infect; 2007 Jan; 54(1):65-74. PubMed ID: 17049991
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effectiveness of vaccination with 23-valent pneumococcal polysaccharide vaccine in preventing hospitalization with laboratory confirmed influenza during the 2009-2010 and 2010-2011 seasons.
    Domínguez A; Castilla J; Godoy P; Delgado-Rodríguez M; Saez M; Soldevila N; Astray J; Mayoral JM; Martín V; Quintana JM; González-Candelas F; Galán JC; Tamames S; Castro A; Baricot M; Garín O; Pumarola T;
    Hum Vaccin Immunother; 2013 Apr; 9(4):865-73. PubMed ID: 23563516
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effect of complex vaccination against pneumococcal, Haemophilus type b infections and influenza in patients with chronic obstructive pulmonary disease].
    Protasov AD; Zhestkov AV; Lavrenteva NE; Kostinov MP; Ryzhkov AA
    Zh Mikrobiol Epidemiol Immunobiol; 2011; (4):80-4. PubMed ID: 21913397
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence and disparities in influenza vaccination among patients with COPD: A French nationwide population study.
    Zysman M; Coquelin A; Le Guen N; Solomiac A; Guecamburu M; Erbault M; Blanchard E; Roche N; Morin S
    Respir Med; 2024 May; 226():107606. PubMed ID: 38522592
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Factors Associated with Influenza Vaccination of Hospitalized Elderly Patients in Spain.
    Domínguez À; Soldevila N; Toledo D; Godoy P; Castilla J; Force L; Morales M; Mayoral JM; Egurrola M; Tamames S; Martín V; Astray J;
    PLoS One; 2016; 11(1):e0147931. PubMed ID: 26824383
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Determinants of uptake of influenza, zoster and pneumococcal vaccines in patients with cardiovascular diseases.
    Benedict Kpozehouen E; Macintyre CR; Tan TC
    Vaccine; 2024 May; 42(15):3404-3409. PubMed ID: 38704255
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison between cohorts vaccinated and unvaccinated against influenza and pneumococcal infection.
    Christenson B; Lundbergh P
    Epidemiol Infect; 2002 Dec; 129(3):515-24. PubMed ID: 12558334
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of physicians' awareness on influenza and pneumococcal vaccination rates and correlates of vaccination in patients with diabetes in Turkey: an epidemiological Study "diaVAX".
    Satman I; Akalin S; Cakir B; Altinel S;
    Hum Vaccin Immunother; 2013 Dec; 9(12):2618-26. PubMed ID: 23887188
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Risk of pneumococcal disease in elderly patients with and without previous vaccination].
    Flores-Copete M; Reolid-Martínez R; López-García M; Alcantud-Lozano P; Mudarra-Tercero E; Azorín-Ras M; Del Campo-Giménez M; Ayuso-Raya MC; Escobar-Rabadán F
    Aten Primaria; 2019 Nov; 51(9):571-578. PubMed ID: 30391017
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influenza vaccination and risk of respiratory failure in patients with chronic obstructive pulmonary disease: A nationwide population-based case-cohort study.
    Huang HH; Chen SJ; Chao TF; Liu CJ; Chen TJ; Chou P; Wang FD
    J Microbiol Immunol Infect; 2019 Feb; 52(1):22-29. PubMed ID: 28927683
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pneumococcal and influenza vaccination coverage among at-risk adults: A 5-year French national observational study.
    Wyplosz B; Fernandes J; Sultan A; Roche N; Roubille F; Loubet P; Fougère B; Moulin B; Duhot D; Vainchtock A; Raguideau F; Lortet-Tieulent J; Blanc E; Moïsi J; Goussiaume G
    Vaccine; 2022 Aug; 40(33):4911-4921. PubMed ID: 35811205
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.